Pfizer Inc. (NYSE: PFE) helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its ...
The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.
Management indicated full year revenue is expected to align with broader market expectations Non GAAP earnings per share ...
“Pfizer appears cheap with a near 7% yield, but capital allocation constraints undermine its investment case. Nearly all of ...
AFP on MSN
Pfizer shares drop on quarterly loss
Pfizer reported a quarterly loss Tuesday following a large write-down, denting shares as it confirmed 2026 financial targets with lower revenues. "Current financial guidance does not anticipate any ...
Pharmaceutical operations remain central to large-cap healthcare discussions Balance sheet positioning frames institutional comparisons Broader sentiment reflects themes seen in s&p 500 chart Pfizer ...
To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results